Indian biotech startup PopVax has launched RNA Foundry, an initiative aimed at developing personalised cancer vaccines using mRNA technology.

The company said the platform is designed to support the creation of vaccines tailored to individual patients. It was announced as part of PopVax’s work in the biotechnology space.

No further details were provided in the input about the launch timeline, clinical stage, or rollout plans.